4.8 Article

Lysine Glutarylation Is a Protein Posttranslational Modification Regulated by SIRT5

Journal

CELL METABOLISM
Volume 19, Issue 4, Pages 605-617

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2014.03.014

Keywords

-

Funding

  1. NIH [GM105933, CA160036, RR020839, GM101171, CA177925, AG000114]
  2. Nancy and Leonard Florsheim Family Fund
  3. National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09301001-007]
  4. Natural Science Foundation of China [31370814]
  5. Shanghai Pujiang Program [13PJ1410300]
  6. American Heart Association [12SDG8840004, 12IRG9010008]
  7. Edward Mallinckrodt Jr. Foundation
  8. Ellison Medical Foundation
  9. National Institutes of Health [AA022146, AG045351]
  10. Duke O'Brien Center for Kidney Research [5P30DK096493-02]
  11. NCI [CA059365-19]
  12. Danish Independent Research Council-Technology and Production Sciences (Sapere Aude grant) [12-132328]
  13. Danish Independent Research Council-Natural Sciences (Steno grant) [10-080907]
  14. Villum Foundation
  15. Carlsberg Foundation
  16. German Research Foundation (Deutsche Forschungsgemeinschaft) [MU1778/3-1]
  17. NIH/NIGMS [5T32GM007105-40]

Ask authors/readers for more resources

We report the identification and characterization of a five-carbon protein posttranslational modification (PTM) called lysine glutarylation (K-glu). This protein modification was detected by immunoblot and mass spectrometry (MS), and then comprehensively validated by chemical and biochemical methods. We demonstrated that the previously annotated deacetylase, sirtuin 5 (SIRT5), is a lysine deglutarylase. Proteome-wide analysis identified 683 Kglu sites in 191 proteins and showed that Kglu is highly enriched on metabolic enzymes and mitochondrial proteins. We validated carbamoyl phosphate synthase 1 (CPS1), the rate-limiting enzyme in urea cycle, as a glutarylated protein and demonstrated that CPS1 is targeted by SIRT5 for deglutarylation. We further showed that glutarylation suppresses CPS1 enzymatic activity in cell lines, mice, and a model of glutaric acidemia type I disease, the last of which has elevated glutaric acid and glutaryl-CoA. This study expands the landscape of lysine acyl modifications and increases our understanding of the deacylase SIRT5.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available